Need help?

Specialty Pharmaceutical Business Investment Opportunities

Showing 1 - 9 of 9 Specialty Pharmaceutical Business Investment Opportunities. Invest in a Specialty Pharmaceutical Business.

Filters
  • Specialty Pharmaceuticals

  • Investment Opportunities

 

Specialty Pharmaceuticals Company Investment Opportunity in Visakhapatnam, India

New biopharmaceutical company with a primary focus on plasma fractionation to manufacture therapeutic plasma proteins.
● Our business has already obtained DCGI approval to manufacture the following proteins in the R&D Unit for the purpose of research and analysis. ● Our R&D unit is set up in 2,000 sq ft space in MN iHub, GenomeValley, Turkapally, Hyderabad with 3 state-of-the-art designated lab spaces for process development, analytical R&D and quality control with a total of 25 staff members. ● Our protein samples are already been extracted and stability studies are being done. ● 150,000 sq ft manufacturing facility is under contraction and will be completed soon. ● By the time the business starts operations, we will have 200 employees. ● Founders are based in the US.
7.1   Visakhapatnam
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 4 Mn for 10%
Contact Business

Profitable Specialty Pharmaceuticals Company Investment Opportunity in Hyderabad, India

Research-based product development partner and medicine developer with 5 global clients seeks investment.
We are working with five clients. We are a research-based product development partner to pharmaceutical companies. Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur. In 3 years, business will reach USD 2 million revenue per year. We signed up new clients this year and have already achieved INR 1 Cr for this year. More clients are in the pipeline. We generate almost equal revenue from fee for service model and in-house asset sale model.
Research-based product development partner and medicine developer with 5 global clients seeks investment.
8.8   Hyderabad
Run Rate Sales
USD 430 thousand
EBITDA Margin
40 %
Financial Investment
USD 360 K for 20%
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Hyderabad, India

IPO ready WHO, GMP certified pharma company with reputed clientele seeking investments.
- We are a multi-faceted organization and have R&D with a proficient team, state-of-the-art facilities, and at par with international standards. - All this, robustly backed by a strong distribution network and path-breaking research work has placed us among India’s fast-growing transnational pharmaceutical organizations. - In India, we have a presence in high-growth specialty segments of Urology, Nephrology, Oncology, Gynaecology, Nutraceuticals, Antibiotics, and pain management where we have been able to provide consistently innovative products. - Some of our clients are 1mg, PharmEasy, and Apollo. - The company is WHO and GMP certified. - We hire part-time employees for the activities of the business. NOTE: Although the company is raising 40 Crores, interested investors can start with an investment as low as 1 lakh in this debt-free company. with buyback guarantee after 1 Year.
IPO ready WHO, GMP certified pharma company with reputed clientele seeking investments.
8.3   Hyderabad
Run Rate Sales
USD 30 million
EBITDA Margin
0 - 10 %
Financial Investment
USD 12 K for 1%
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Kathmandu, Nepal

Pharma company with 3,000+ customers seeks investment for business expansion.
- We are a pharma company with in-house manufacturing and our own R&D department. - We majorly deal with allopathic medicines. - Our total annual manufacturing capacity is NPR 100 crore but currently, we are operating at 25% of our total manufacturing capacity. - We have 3,000 healthcare professionals and customers who support our products. - The growth is stagnant due to capital problems. With the right investment, we can double the business growth. - Our products are sold under our own brand name. - We are a WHO GMP-certified company.
7.2   Kathmandu
Run Rate Sales
USD 2.3 million
EBITDA Margin
20 - 30 %
Financial Investment
USD 7 Mn for 50%
Contact Business

Specialty Pharmaceuticals Business Investment Opportunity in Mumbai, India

Manufacturer of nutrition supplements with 20 SKUs and a reputed brand seeks financial investment.
- We are a manufacturer of science-based and clinically validated nutritional supplements and herbal formulations. - Our company has in-house product development and manufacturing capability. - On a daily basis we can manufacture 1 lakh capsules and 500 litres of various powders. - In total, we have 20 SKUs and 1 patent. - We only deal in B2C transactions and our main clients are doctors and hospitals. - Our products are sold under our own brand name. - The business has 3 partners with an equal stake in the company. - The company has INR 15 lakhs of outstanding liabilities as bank overdraft.
6.4   Mumbai
Run Rate Sales
USD 500 thousand
EBITDA Margin
25 %
Financial Investment
USD 180 K for 30%
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Nieuwegein, Netherlands

Vertically integrated firm that will be able to produce pharma grade API's from own cannabinoids.
Updates on the business: The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids. The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University. Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program. Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation. We have received an installation license for such end products and as the project progresses we will add new products to the list: - Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption; - Hemp oil in drops for oral consumption > 0.2% THC; - Hemp oil for sublingual oral consumption (spray) > 0.2% THC; - Soft cannabis capsules for oral consumption > 0.2% THC; - Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption. At the moment we have: License and permits; Architectural and engineering plans; Purchase offers from equipment suppliers; All described production processes and laboratories; Long-term land lease for 30+ years with first an option of first to purchase it; Long-term lease and right of build on the neighboring land for the second stage of construction; The entire legal structure of the holding; Verification of processes and architectural solutions under EU GACP & EU GMP standards. By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years. Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards. The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line. Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.
Vertically integrated firm that will be able to produce pharma grade API's from own cannabinoids.
8.9   Athens
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 1.6 Mn for 15%
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Butwal, Nepal

Pharmaceutical manufacturing company that specializes in allopathic medicines.
- We are a pharma company established in Nepal and have a pharma wholesale unit. - The business has tie-ups with many wholesale and retail outlet. - Pharmaceutical industry in Nepal has been emerging as the best investment sector in the last few years. - We are planning to start our own manufacturing unit. The unit is not operational as of now. - The building and some machinery are ready. - We specialize in allopathic medicines. - Have more than 15 years of experience in this sector.
Pharmaceutical manufacturing company that specializes in allopathic medicines.
7.1   Butwal
Run Rate Sales
Nil
EBITDA Margin
30 - 40 %
Financial Investment
USD 900 K for 40%
Contact Business

Profitable Specialty Pharmaceuticals Company Investment Opportunity in Bangalore, India

Company with 170 pharma and R&D alliances that provides clinical trials and molecular innovations.
- We are a global speciality contract research organization (CRO) headquartered in India. - Operate mainly in India, Europe, and the Middle East. We support our clients through pharma drug development and clinical trials. - Our company directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe, N. America and South Korea. - We are a quality leader in our industry and focus on the therapeutic areas of immunology, respiratory and allergy, endocrinology, oncology, GI, and CNS based on experience and expertise. - We have 170 pharma and R&D companies who are our clients. - Our customers are mainly from pharma, R&D, manufacturing, fertilizers, seeds, pesticides, and diagnostics. - Company focuses on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics, and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, and rheumatology. These include, but are not limited to, small molecules, recombinant proteins, monoclonal antibodies (mAbs), drug-delivery devices, and diagnostics in oncology and immunology. - Due to Covid we saw an increase in the demand for our services. This is the reason for the high growth rate of our sales.
6.2   Bangalore
Run Rate Sales
USD 700 thousand
EBITDA Margin
40 %
Financial Investment
USD 1.2 Mn for 50%
Contact Business

Profitable Specialty Pharmaceuticals Company Investment Opportunity in Bangkok, Thailand

Seeking Investment for production and market new pharmaceuticals.
- Our company developing and market potential pharmaceutical medicines that have no side effects. - The business has invested heavily in the research and development of anti-viral drugs. - Today, we have finished R&D and are ready to start production of a new drug that can help to prevent and treat many diseases including COVID-19. - The investment will be utilized to commence production and fulfil purchase orders from around the world.
Seeking Investment for production and market new pharmaceuticals.
7.1   Bangkok
Run Rate Sales
Nil
EBITDA Margin
50 %
Financial Investment
USD 800 K for 30%
Contact Business

Frequently
Asked
Questions

  • How many specialty pharmaceutical business investment opportunities are listed on SMERGERS?
    There are 9 active and verified specialty pharmaceutical business investment opportunities listed on SMERGERS as of 21 February 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more